Fuse Medical, Inc. (FZMD)
USD 0.09
(-9.91%)
USD 0.09
(-9.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.45 Million USD | -52.88% |
| 2022 | 3.09 Million USD | 295.11% |
| 2021 | -1.58 Million USD | -10.85% |
| 2020 | -1.43 Million USD | 56.81% |
| 2019 | -3.31 Million USD | -183.8% |
| 2018 | 3.95 Million USD | 465.63% |
| 2017 | 699.67 Thousand USD | 219.41% |
| 2016 | -585.93 Thousand USD | 26.9% |
| 2015 | -801.54 Thousand USD | 42.95% |
| 2014 | -1.4 Million USD | -1179.0% |
| 2013 | -109.85 Thousand USD | -8.14% |
| 2012 | -101.58 Thousand USD | 16.91% |
| 2011 | -122.26 Thousand USD | 22.35% |
| 2010 | -157.46 Thousand USD | -42.68% |
| 2009 | -110.36 Thousand USD | -34.95% |
| 2008 | -81.78 Thousand USD | -100.23% |
| 2007 | -40.84 Thousand USD | 53.62% |
| 2006 | -88.05 Thousand USD | 15.42% |
| 2005 | -104.11 Thousand USD | 71.56% |
| 2004 | -366.12 Thousand USD | -156.8% |
| 2003 | -142.57 Thousand USD | 23.12% |
| 2002 | -185.44 Thousand USD | 9.47% |
| 2001 | -204.84 Thousand USD | 59.27% |
| 2000 | -503 Thousand USD | -151.5% |
| 1999 | -200 Thousand USD | -183.33% |
| 1998 | 240 Thousand USD | -7.69% |
| 1997 | 260 Thousand USD | 0.0% |
| 1996 | 260 Thousand USD | 0.0% |
| 1995 | 260 Thousand USD | 0.0% |
| 1994 | - USD | -100.0% |
| 1993 | 90 Thousand USD | 121.95% |
| 1992 | -410 Thousand USD | 82.85% |
| 1991 | -2.39 Million USD | -378.0% |
| 1990 | -500 Thousand USD | -212.5% |
| 1989 | -160 Thousand USD | 78.08% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | 307.58 Thousand USD | 234.69% |
| 2023 FY | 1.45 Million USD | -52.88% |
| 2023 Q1 | -228.36 Thousand USD | -106.42% |
| 2022 Q1 | -358.28 Thousand USD | -1.77% |
| 2022 FY | 3.09 Million USD | 295.11% |
| 2022 Q4 | 3.55 Million USD | 38059.56% |
| 2022 Q3 | -9376.00 USD | 89.95% |
| 2022 Q2 | -93.31 Thousand USD | 73.95% |
| 2021 Q1 | -453.32 Thousand USD | -333.13% |
| 2021 Q2 | -85.48 Thousand USD | 81.14% |
| 2021 Q4 | -352.05 Thousand USD | 49.49% |
| 2021 FY | -1.58 Million USD | -10.85% |
| 2021 Q3 | -697.03 Thousand USD | -715.44% |
| 2020 Q2 | -423.43 Thousand USD | 67.02% |
| 2020 Q4 | 194.45 Thousand USD | 141.6% |
| 2020 FY | -1.43 Million USD | 56.81% |
| 2020 Q1 | -1.28 Million USD | -191.65% |
| 2020 Q3 | 80.48 Thousand USD | 119.01% |
| 2019 FY | -3.31 Million USD | -183.8% |
| 2019 Q1 | -510.99 Thousand USD | -108.47% |
| 2019 Q2 | -142.14 Thousand USD | 72.18% |
| 2019 Q3 | -4.06 Million USD | -2759.21% |
| 2019 Q4 | 1.4 Million USD | 134.47% |
| 2018 FY | 3.95 Million USD | 465.63% |
| 2018 Q2 | -1.61 Million USD | -119.78% |
| 2018 Q3 | 277.18 Thousand USD | 117.16% |
| 2018 Q4 | 6.03 Million USD | 2075.7% |
| 2018 Q1 | -734.96 Thousand USD | -192.78% |
| 2017 Q4 | 792.15 Thousand USD | 2433.68% |
| 2017 Q2 | -7333.00 USD | 93.7% |
| 2017 Q3 | 31.26 Thousand USD | 526.36% |
| 2017 Q1 | -116.4 Thousand USD | 55.27% |
| 2017 FY | 699.67 Thousand USD | 219.41% |
| 2016 FY | -585.93 Thousand USD | 26.9% |
| 2016 Q4 | -260.25 Thousand USD | -129.51% |
| 2016 Q3 | -113.39 Thousand USD | -28.27% |
| 2016 Q1 | -123.88 Thousand USD | -985.73% |
| 2016 Q2 | -88.4 Thousand USD | 28.64% |
| 2015 Q4 | 13.98 Thousand USD | 102.91% |
| 2015 FY | -801.54 Thousand USD | 42.95% |
| 2015 Q1 | -217.11 Thousand USD | 38.34% |
| 2015 Q2 | -117.77 Thousand USD | 45.76% |
| 2015 Q3 | -480.64 Thousand USD | -308.11% |
| 2014 FY | -1.4 Million USD | -1179.0% |
| 2014 Q1 | -125.88 Thousand USD | -159.95% |
| 2014 Q3 | -473.42 Thousand USD | -4.36% |
| 2014 Q4 | -352.11 Thousand USD | 25.62% |
| 2014 Q2 | -453.62 Thousand USD | -260.36% |
| 2013 FY | -109.85 Thousand USD | -8.14% |
| 2013 Q2 | -22.41 Thousand USD | 8.42% |
| 2013 Q3 | -30.8 Thousand USD | -37.45% |
| 2013 Q4 | -48.42 Thousand USD | -57.21% |
| 2013 Q1 | -24.47 Thousand USD | 23.94% |
| 2012 Q3 | -26.39 Thousand USD | -10.58% |
| 2012 FY | -101.58 Thousand USD | 16.91% |
| 2012 Q4 | -32.17 Thousand USD | -21.91% |
| 2012 Q2 | -23.86 Thousand USD | -7.48% |
| 2012 Q1 | -22.2 Thousand USD | 23.75% |
| 2011 Q3 | -20.71 Thousand USD | -17.04% |
| 2011 Q4 | -29.12 Thousand USD | -40.58% |
| 2011 Q1 | -24.92 Thousand USD | 57.69% |
| 2011 FY | -122.26 Thousand USD | 22.35% |
| 2011 Q2 | -17.7 Thousand USD | 28.99% |
| 2010 Q4 | -58.91 Thousand USD | 24.24% |
| 2010 Q2 | -21.68 Thousand USD | 7.54% |
| 2010 Q1 | -23.44 Thousand USD | 32.16% |
| 2010 Q3 | -77.76 Thousand USD | -258.7% |
| 2010 FY | -157.46 Thousand USD | -42.68% |
| 2009 Q4 | -34.56 Thousand USD | -39.98% |
| 2009 Q3 | -24.69 Thousand USD | 0.91% |
| 2009 Q2 | -24.92 Thousand USD | 1.57% |
| 2009 Q1 | -25.31 Thousand USD | 28.55% |
| 2009 FY | -110.36 Thousand USD | -34.95% |
| 2008 Q1 | -21.81 Thousand USD | -37.25% |
| 2008 Q3 | -25.87 Thousand USD | -42.3% |
| 2008 FY | -81.78 Thousand USD | -100.23% |
| 2008 Q4 | -35.43 Thousand USD | -36.93% |
| 2008 Q2 | -18.18 Thousand USD | 16.65% |
| 2007 FY | -40.84 Thousand USD | 53.62% |
| 2007 Q2 | -2603.00 USD | 60.54% |
| 2007 Q3 | -18.1 Thousand USD | -595.54% |
| 2007 Q1 | -6597.00 USD | 51.27% |
| 2007 Q4 | -15.89 Thousand USD | 12.2% |
| 2006 Q2 | -10.93 Thousand USD | 13.55% |
| 2006 FY | -88.05 Thousand USD | 15.42% |
| 2006 Q4 | -13.53 Thousand USD | 66.62% |
| 2006 Q1 | -12.65 Thousand USD | 47.07% |
| 2006 Q3 | -40.56 Thousand USD | -270.83% |
| 2005 FY | -104.11 Thousand USD | 71.56% |
| 2005 Q3 | -13.02 Thousand USD | 26.92% |
| 2005 Q2 | -17.82 Thousand USD | 60.49% |
| 2005 Q1 | -45.12 Thousand USD | -60.4% |
| 2005 Q4 | -23.9 Thousand USD | -83.47% |
| 2004 FY | -366.12 Thousand USD | -156.8% |
| 2004 Q3 | -261.15 Thousand USD | -815.51% |
| 2004 Q4 | -28.13 Thousand USD | 89.23% |
| 2004 Q2 | -28.52 Thousand USD | 10.18% |
| 2004 Q1 | -31.76 Thousand USD | 28.92% |
| 2003 Q4 | -44.68 Thousand USD | -78.24% |
| 2003 Q1 | -36.35 Thousand USD | 10.12% |
| 2003 Q2 | -40.69 Thousand USD | -11.92% |
| 2003 Q3 | -25.07 Thousand USD | 38.39% |
| 2003 FY | -142.57 Thousand USD | 23.12% |
| 2002 Q2 | -59.55 Thousand USD | -689.25% |
| 2002 Q1 | -7546.00 USD | 85.24% |
| 2002 Q3 | -67.2 Thousand USD | -12.84% |
| 2002 Q4 | -40.45 Thousand USD | 39.81% |
| 2002 FY | -185.44 Thousand USD | 9.47% |
| 2001 FY | -204.84 Thousand USD | 59.27% |
| 2001 Q4 | -51.13 Thousand USD | 7.24% |
| 2001 Q3 | -55.11 Thousand USD | -50.06% |
| 2001 Q2 | -36.73 Thousand USD | 30.45% |
| 2001 Q1 | -52.81 Thousand USD | 12.25% |
| 2000 Q3 | 40 Thousand USD | 166.67% |
| 2000 Q4 | -60.18 Thousand USD | -250.46% |
| 2000 FY | -503 Thousand USD | -151.5% |
| 2000 Q1 | -110 Thousand USD | -37.5% |
| 2000 Q2 | -60 Thousand USD | 45.45% |
| 1999 Q1 | 60 Thousand USD | -14.29% |
| 1999 Q2 | 10 Thousand USD | -83.33% |
| 1999 FY | -200 Thousand USD | -183.33% |
| 1999 Q3 | -60 Thousand USD | -700.0% |
| 1999 Q4 | -80 Thousand USD | -33.33% |
| 1998 Q3 | 70 Thousand USD | 0.0% |
| 1998 FY | 240 Thousand USD | -7.69% |
| 1998 Q1 | 70 Thousand USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q4 | 70 Thousand USD | 0.0% |
| 1997 FY | 260 Thousand USD | 0.0% |
| 1997 Q4 | 70 Thousand USD | 16.67% |
| 1997 Q3 | 60 Thousand USD | -14.29% |
| 1997 Q2 | 70 Thousand USD | -12.5% |
| 1997 Q1 | 80 Thousand USD | 14.29% |
| 1996 Q2 | - USD | -100.0% |
| 1996 FY | 260 Thousand USD | 0.0% |
| 1996 Q1 | 80 Thousand USD | 14.29% |
| 1996 Q4 | 70 Thousand USD | -12.5% |
| 1996 Q3 | 80 Thousand USD | 0.0% |
| 1995 Q1 | 70 Thousand USD | 16.67% |
| 1995 Q2 | 70 Thousand USD | 0.0% |
| 1995 Q4 | 70 Thousand USD | 0.0% |
| 1995 FY | 260 Thousand USD | 0.0% |
| 1995 Q3 | - USD | -100.0% |
| 1994 Q3 | 70 Thousand USD | 0.0% |
| 1994 Q4 | 60 Thousand USD | -14.29% |
| 1994 FY | - USD | -100.0% |
| 1993 Q1 | 20 Thousand USD | 300.0% |
| 1993 Q2 | 80 Thousand USD | 300.0% |
| 1993 FY | 90 Thousand USD | 121.95% |
| 1993 Q3 | -20 Thousand USD | -125.0% |
| 1992 Q1 | -120 Thousand USD | 68.42% |
| 1992 FY | -410 Thousand USD | 82.85% |
| 1992 Q4 | -10 Thousand USD | -102.78% |
| 1992 Q3 | 360 Thousand USD | 244.0% |
| 1992 Q2 | -250 Thousand USD | -108.33% |
| 1991 Q1 | -430 Thousand USD | -4400.0% |
| 1991 FY | -2.39 Million USD | -378.0% |
| 1991 Q4 | -380 Thousand USD | 76.25% |
| 1991 Q3 | -1.6 Million USD | -332.43% |
| 1991 Q2 | -370 Thousand USD | 13.95% |
| 1990 FY | -500 Thousand USD | -212.5% |
| 1990 Q2 | -160 Thousand USD | -6.67% |
| 1990 Q1 | -150 Thousand USD | 21.05% |
| 1990 Q3 | - USD | 100.0% |
| 1990 Q4 | 10 Thousand USD | 0.0% |
| 1989 Q3 | -290 Thousand USD | -123.08% |
| 1989 FY | -160 Thousand USD | 78.08% |
| 1989 Q2 | -130 Thousand USD | 0.0% |
| 1989 Q4 | -190 Thousand USD | 34.48% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 301.984% |
| IR-Med Inc. | -4.9 Million USD | 129.741% |
| Polarean Imaging plc | -11.88 Million USD | 112.284% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | -269.761% |
| Avitar, Inc. | -2.25 Million USD | 164.611% |
| AVITA Medical, Inc. | -39.16 Million USD | 103.727% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 225.319% |
| Össur hf. | 58.38 Million USD | 97.5% |
| Zecotek Photonics Inc. | -3.51 Million USD | 141.488% |
| QHSLab, Inc. | -468.36 Thousand USD | 411.717% |
| Wellstar International, Inc. | -3.1 Million USD | 146.967% |
| Össur hf. | 58.38 Million USD | 97.5% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 37.927% |
| Escalon Medical Corp. | -125.26 Thousand USD | 1265.538% |
| Aurora Spine Corporation | -1.68 Million USD | 186.874% |
| BrainsWay Ltd. | -4.19 Million USD | 134.786% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 112.699% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 340.513% |
| Vivos Inc. | -2.89 Million USD | 150.435% |
| MicroPort Scientific Corporation | -477.62 Million USD | 100.306% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 768.264% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 182.12% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 449.246% |
| Nanomix Corporation | -12.33 Million USD | 111.838% |
| Theraclion SA | -3.67 Million USD | 139.727% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 293.891% |
| Positron Corporation | -1.63 Million USD | 189.093% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 155.276% |
| Lombard Medical, Inc. | -31.03 Million USD | 104.704% |
| ALR Technologies Inc. | -11.89 Million USD | 112.272% |
| Stratec SE | 14.42 Million USD | 89.88% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 2194.91% |
| Heart Tronics, Inc. | -13.32 Million USD | 110.955% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 1263.077% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 110.402% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 105.657% |
| VMS Rehab Systems, Inc. | 46.44 USD | -3143663.997% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 141.845% |
| Ingen Technologies, Inc. | -5.06 Million USD | 128.845% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 261.185% |
| United American Healthcare Corporation | 723 Thousand USD | -101.931% |
| ECGI Holdings, Inc. | -3.61 Million USD | 140.432% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 321.871% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 303.664% |
| Urologix, Inc. | -7.6 Million USD | 119.19% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 186.194% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 167.043% |
| SS Innovations International, Inc. | -20.94 Million USD | 106.971% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 281.357% |
| Smith & Nephew plc | 263 Million USD | 99.445% |
| NIOX Group Plc | 13.64 Million USD | 89.297% |
| Broncus Holding Corporation | -28.09 Million USD | 105.197% |
| Brain Scientific Inc. | -12.34 Million USD | 111.827% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 104.98% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 1011.065% |